New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 26, 2013
12:00 EDTDYAXDyax falls 31.7%
Dyax is down 31.7%, or $1.31, to $2.82
News For DYAX From The Last 14 Days
Check below for free stories on DYAX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
08:02 EDTDYAXDyax names Todd Bazemore as Chief Commercial Officer
Dyax Corp. announced the appointment of Todd Bazemore as Executive Vice President and Chief Commercial Officer. Bazemore will be responsible for leading Dyax’s commercial organization which currently markets KALBITOR for the treatment of acute attacks of hereditary angioedema in patients 12 years of age and older. Bazemore most recently served as Vice President, Managed Markets at Sunovion Pharmaceuticals.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use